Dr. Jacqueline S. Garcia, MD
Claim this profileDana-Farber Cancer Institute
Affiliated Hospitals
Dana Farber Cancer Institute
Brigham And Women's Hospital
Clinical Trials Jacqueline S. Garcia, MD is currently running
Ivosidenib + Venetoclax +/- Azacitidine
for Leukemia
This phase Ib/II trial studies the side effects and best dose of venetoclax and how well it works when given together with ivosidenib with or without azacitidine, in treating patients with IDH1-mutated hematologic malignancies. Venetoclax and ivosidenib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving ivosidenib and venetoclax with azacitidine may work better in treating patients with hematologic malignancies compared to ivosidenib and venetoclax alone.
Recruiting
3 awards
Phase 1 & 2
Talazoparib
for Leukemia
This research study is testing if Talazoparib is an effective treatment for patients with AML and MDS that have a mutation in the cohesin complex.
Recruiting
1 award
Phase 1
3 criteria
More about Jacqueline S. Garcia, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Jacqueline S. Garcia, MD has experience with
- Venetoclax
- Azacitidine
- Decitabine
- Busulfan
- Decitabine/cedazuridine
- Fludarabine
Breakdown of trials Jacqueline S. Garcia, MD has run
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Leukemia
Myeloproliferative Disorder
Myeloproliferative Neoplasms
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jacqueline S. Garcia, MD specialize in?
Jacqueline S. Garcia, MD focuses on Acute Myeloid Leukemia and Myelodysplastic Syndrome. In particular, much of their work with Acute Myeloid Leukemia has involved IDH positive patients, or patients who are undergoing treatment.
Is Jacqueline S. Garcia, MD currently recruiting for clinical trials?
Yes, Jacqueline S. Garcia, MD is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Jacqueline S. Garcia, MD has studied deeply?
Yes, Jacqueline S. Garcia, MD has studied treatments such as Venetoclax, Azacitidine, Decitabine.
What is the best way to schedule an appointment with Jacqueline S. Garcia, MD?
Apply for one of the trials that Jacqueline S. Garcia, MD is conducting.
What is the office address of Jacqueline S. Garcia, MD?
The office of Jacqueline S. Garcia, MD is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.